Search research articles
Contact Us
Filters
Showing results (1-10 of 166) with videos related to
Page
of 17
Sort By:
Molecular Biosystems
|
August 2, 2006
On the track of antitumour ribonucleases
Antoni Benito, Marc Ribó, Maria Vilanova
Current Pharmaceutical Biotechnology
|
August 5, 2008
Intracellular routing of cytotoxic pancreatic-type ribonucleases
Antoni Benito, Maria Vilanova, Marc Ribó
Pharmaceutics
|
January 13, 2021
Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
Jessica Castro, Marc Ribó, Maria Vilanova, et al.
Molecular Pharmaceutics
|
September 1, 2009
Bactericidal activity engineered on human pancreatic ribonuclease and onconase
Gerard Torrent, Marc Ribó, Antoni Benito, et al.
Biopolymers
|
April 18, 2009
Mapping the stability clusters in bovine pancreatic ribonuclease A
Roger Vilà, Antoni Benito, Marc Ribó, et al.
The FEBS Journal
|
March 8, 2006
Characterization of the dimerization process of a domain-swapped dimeric variant of human pancreatic ribonuclease
Montserrat Rodríguez, Antoni Benito, Marc Ribó, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 8, 2020
Protein Splicing: From the Foundations to the Development of Biotechnological Applications
Alejandro Romero-Casañas, Verónica Gordo, Jessica Castro, et al.
Oncotarget
|
February 27, 2016
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells
Anna Vert, Jessica Castro, Marc Ribó, et al.
Biological Chemistry
|
November 4, 2008
Contribution of the C30/C75 disulfide bond to the biological properties of onconase
Gerard Torrent, Antoni Benito, Jessica Castro, et al.
Protein Science : a Publication of the Protein Society
|
April 7, 2006
The contribution of the residues from the main hydrophobic core of ribonuclease A to its pressure-folding transition state
Josep Font, Antoni Benito, Reinhard Lange, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 166) with videos related to
Sort By:
Page
of 17
Molecular Biosystems
|
August 2, 2006
On the track of antitumour ribonucleases
Antoni Benito, Marc Ribó, Maria Vilanova
Current Pharmaceutical Biotechnology
|
August 5, 2008
Intracellular routing of cytotoxic pancreatic-type ribonucleases
Antoni Benito, Maria Vilanova, Marc Ribó
Pharmaceutics
|
January 13, 2021
Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
Jessica Castro, Marc Ribó, Maria Vilanova, et al.
Molecular Pharmaceutics
|
September 1, 2009
Bactericidal activity engineered on human pancreatic ribonuclease and onconase
Gerard Torrent, Marc Ribó, Antoni Benito, et al.
Biopolymers
|
April 18, 2009
Mapping the stability clusters in bovine pancreatic ribonuclease A
Roger Vilà, Antoni Benito, Marc Ribó, et al.
The FEBS Journal
|
March 8, 2006
Characterization of the dimerization process of a domain-swapped dimeric variant of human pancreatic ribonuclease
Montserrat Rodríguez, Antoni Benito, Marc Ribó, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 8, 2020
Protein Splicing: From the Foundations to the Development of Biotechnological Applications
Alejandro Romero-Casañas, Verónica Gordo, Jessica Castro, et al.
Oncotarget
|
February 27, 2016
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells
Anna Vert, Jessica Castro, Marc Ribó, et al.
Biological Chemistry
|
November 4, 2008
Contribution of the C30/C75 disulfide bond to the biological properties of onconase
Gerard Torrent, Antoni Benito, Jessica Castro, et al.
Protein Science : a Publication of the Protein Society
|
April 7, 2006
The contribution of the residues from the main hydrophobic core of ribonuclease A to its pressure-folding transition state
Josep Font, Antoni Benito, Reinhard Lange, et al.
Page
of 17